Liberty Health Sciences Opens Its First South Florida Dispensary

Liberty Health Sciences Inc. (OTCMKTS:LHSIF) has achieved another milestone in the provision of its services. The Canadian cannabis company has added its portfolio of dispensaries by opening another one in South Florida. The new state-of-the-art dispensary is situated at 6827 Bird Road in the heart of Miami. It is the first of its kind to open in South Florida. However, it is the eighth dispensary that the company is opening in its pursuit to offer access to premium quality medical marijuana products.

Story continues below

The company’s CEO George Scorsis has expressed their desire to embrace measures, which will keep up to the patient demands. The company’s primary aim is to have the more than 2.7 million people living in South Florida access the best products available.

Liberty’s focus on operational excellence from seed to sale and beyond

The new dispensary will offer services to customers in Miami-Dade County, which is one of the most populated counties in Florida. It will operate from 10 a.m. to 7 p.m Monday to Friday, 10 a.m. to 5 p.m. on Saturdays and 12 p.m. to 5 p.m. on Sundays. The company has put up delivery systems, which will ensure consumers are gaining access to a diverse selection of Medicinal Products.

Its strategies are so unique according to Scorsis, who affirms, “No other company has a brand-house and selection like ours. This demonstrates that not only do our partner brands trust and believe in us to deliver against their goals and objectives.”

Liberty’s measured approach to expansion

The cannabis provider is also working towards maximization of returns to shareholders. Nonetheless, it has bigger goals and objectives regarding tapping into expansion opportunities.

The company’s 360 facility in Gainesville is currently operating on 20,000 square feet of cultivation space. However, plans are underway to have this expanded and completed in stages. There is already working an 80,000 square feet likely to come into completion by the end of February 2019.

Meanwhile, it is already investing in its research and development capabilities, which will ensure that the company is in line with its vision.

An ad to help with our costs